Evidence map›Paper›PMID 36942083›Full record

ArticleApplied surface science2023

Omicron SARS-CoV-2 antiviral on poly(lactic acid) with nanostructured copper coating: Wear effects.

Daniel J da Silva, Adriana Duran, Fernando L A Fonseca, Duclerc F Parra, Rodrigo F Bueno, Derval S Rosa

Abstract read
In one paragraph

Article in Applied surface science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel J da SilvaCenter for Engineering, Modeling, and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Bangú, Santo André, SP, Brazil.
Adriana DuranCenter for Engineering, Modeling, and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Bangú, Santo André, SP, Brazil.
Fernando L A FonsecaFaculty of Medicine of ABC (FMABC), Department of Clinical Analysis, Av. Lauro Gomes, 2000, Santo André, SP, Brazil.
Duclerc F ParraNuclear and Energy Research Institute, IPEN-CNEN/SP, Av. Prof. Lineu Prestes, 2242, São Paulo, SP, Brazil.
Rodrigo F BuenoCoordinator of the COVID-19 Monitoring Network in Wastewater National Water and Basic Sanitation Agency, Ministry of Science, Technology and Innovation and Ministry of Health, Brazil. Center for Engineering, Modeling, and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Bangú, Santo André, SP, Brazil.
Derval S RosaCenter for Engineering, Modeling, and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Bangú, Santo André, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface modification corresponds to a set of viable technological approaches to introduce antimicrobial properties in materials that do not have such characteristics. Antimicrobial materials are important to prevent the proliferation of microorganisms and minimize the transmission of diseases caused by pathogens. Herein, poly(lactic acid) (PLA) was decorated with nanocones through copper sputtering followed by a plasma etching. Antiviral assays by Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) show that nanostructured Cu-coated PLA has high antiviral activity against Omicron SARS-CoV-2, showing a relative reduction in the amplified RNA (78.8 ± 3.9 %). Atomic Force Microscopy (AFM), X-ray Photoelectron Spectroscopy (XPS), and wear-resistance tests show that 20 wear cycles disrupt the surface nanocone patterns and significantly reduce the Cu content at the surface of the nanostructured Cu-coated PLA, leading to total loss of the antiviral properties of nanostructured PLA against Omicron SARS-CoV-2.

Indexed as

CopperNanotechnologyPLAPlasmaSARS-CoV-2Wear

Identifiers

PMID36942083
PMCPMC10015093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.